Veeva Compass Prescriber & National

Veeva Compass Prescriber & National Overview

Veeva Compass provides projected prescription and procedure data at different levels of granularity for both retail and non-retail products in the U.S. market, encompassing over 4,000 brands. This allows for precise commercial planning and execution.

Compass Prescriber offers data at the Healthcare Provider (HCP), Healthcare Organization (HCO), and ZIP code levels. This is particularly beneficial for targeting and segmentation, helping users prioritize customer segments effectively within complex markets.

Compass National extends these projections to the state and national levels, enabling broader strategic insights. Both levels offer unlimited access to the projected data, facilitating various commercial operations such as forecasting, market share tracking, and the formulation of a robust commercial strategy.

• Unlimited data access at HCP, HCO, ZIP, state, and national levels
• Supports over 4,000 brands
• Useful for commercial operations including forecasting and market share tracking

By providing a modern, transparent view of the market, where products aren't confined to retail distribution alone, Veeva Compass empowers companies to enhance precision in both planning and execution phases of commercial operations. Testimonials from industry leaders underscore how the data facilitated improved internal and external performance reporting and accelerated product launches.

Veeva Compass's trusted data is celebrated for transforming traditional market and competitive intelligence approaches, particularly useful in pre-launch field planning.

Additional Features and Impact

Veeva Compass also offers insights into modern trends in commercial data, providing solutions to long-standing industry challenges. The platform's ability to deliver more precise views, covering extensive historical data and transaction analytics, has made it a preferred choice in the industry, as evidenced by its recognition with the 'Analytics Solution of the Year – Biotech Breakthrough Award 2024'.